Suppr超能文献

直面医疗保险计划 D 中的“医疗体系使用偏倚”:倾向评分法在混杂调整中的比较效果。

Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment.

机构信息

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2(Suppl 2):90-8. doi: 10.1002/pds.3250.

Abstract

PURPOSE

Under Medicare Part D, patient characteristics influence plan choice, which in turn influences Part D coverage gap entry. We compared predefined propensity score (PS) and high-dimensional propensity score (hdPS) approaches to address such "confounding by health system use" in assessing whether coverage gap entry is associated with cardiovascular events or death.

METHODS

We followed 243,079 Medicare patients aged 65+ years with linked prescription, medical, and plan-specific data in 2005-2007. Patients reached the coverage gap and were followed until an event or year's end. Exposed patients were responsible for drug costs in the gap; unexposed patients (patients with non-Part D drug insurance and Part D patients receiving a low-income subsidy) received financial assistance. Exposed patients were 1:1 PS-matched or hdPS-matched to unexposed patients. The PS model included 52 predefined covariates; the hdPS model added 400 empirically identified covariates. Hazard ratios for death and any of five cardiovascular outcomes were compared. In sensitivity analyses, we explored residual confounding using only low-income subsidy patients in the unexposed group.

RESULTS

In unadjusted analyses, exposed patients had no greater hazard of death (HR = 1.00; 95%CI, 0.84-1.20) or other outcomes. PS-matched (HR = 1.29; 0.99-1.66) and hdPS-matched (HR = 1.11; 0.86-1.42) analyses showed elevated but non-significant hazards of death. In sensitivity analyses, the PS analysis showed a protective effect (HR = 0.78; 0.61-0.98), whereas the hdPS analysis (HR = 1.06; 0.82-1.37) confirmed the main hdPS findings.

CONCLUSION

Although the PS-matched analysis suggested elevated but non-significant hazards of death among patients with no financial assistance during the gap, the hdPS analysis produced lower estimates that were stable across sensitivity analyses.

摘要

目的

在医疗保险 Part D 计划下,患者特征会影响计划选择,进而影响 Part D 保险覆盖缺口的进入。我们比较了预先定义的倾向评分 (PS) 和高维倾向评分 (hdPS) 方法,以解决在评估覆盖缺口进入是否与心血管事件或死亡相关时,“因健康系统使用而导致的混杂”问题。

方法

我们对 2005 年至 2007 年期间,243079 名年龄在 65 岁以上的有相关处方、医疗和计划特定数据的医疗保险患者进行了随访。患者进入覆盖缺口后,会一直随访至发生事件或年底。暴露组患者需承担缺口内的药物费用;未暴露组患者(未参加 Part D 药物保险的患者和接受低收入补贴的 Part D 患者)则获得财政援助。暴露组患者与未暴露组患者按 1:1 PS 匹配或 hdPS 匹配。PS 模型包含 52 个预先定义的协变量;hdPS 模型增加了 400 个经验确定的协变量。比较了死亡和五个心血管结局的任何一个的死亡风险比。在敏感性分析中,我们仅使用未暴露组中的低收入补贴患者来探索残余混杂。

结果

在未调整分析中,暴露组患者的死亡风险(HR=1.00;95%CI,0.84-1.20)或其他结局均无显著增加。PS 匹配(HR=1.29;0.99-1.66)和 hdPS 匹配(HR=1.11;0.86-1.42)分析显示,死亡风险升高但无统计学意义。在敏感性分析中,PS 分析显示出保护作用(HR=0.78;0.61-0.98),而 hdPS 分析(HR=1.06;0.82-1.37)则证实了主要的 hdPS 发现。

结论

尽管 PS 匹配分析表明在缺口期间没有财政援助的患者死亡风险升高但无统计学意义,但 hdPS 分析得出的估计值较低且在敏感性分析中稳定。

相似文献

2
Beneficiaries with cardiovascular disease and thePart D coverage gap.
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):387-95. doi: 10.1161/CIRCOUTCOMES.111.964866. Epub 2012 Apr 17.
3
Association between the Part D coverage gap and adverse health outcomes.
J Am Geriatr Soc. 2012 Aug;60(8):1408-17. doi: 10.1111/j.1532-5415.2012.04073.x. Epub 2012 Jul 12.
4
Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
PLoS Med. 2011 Aug;8(8):e1001075. doi: 10.1371/journal.pmed.1001075. Epub 2011 Aug 16.
5
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
J Manag Care Spec Pharm. 2015 Oct;21(10):956-64. doi: 10.18553/jmcp.2015.21.10.956.
6
Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.
J Gen Intern Med. 2011 Oct;26(10):1195-200. doi: 10.1007/s11606-011-1766-x. Epub 2011 Jun 28.
7
Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.
8
Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

引用本文的文献

3
Pharmaceutical policies: effects of regulating drug insurance schemes.
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
4
Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.
Clin Epidemiol. 2018 Jul 6;10:771-788. doi: 10.2147/CLEP.S166545. eCollection 2018.
5
Performance of the high-dimensional propensity score in adjusting for unmeasured confounders.
Eur J Clin Pharmacol. 2016 Dec;72(12):1497-1505. doi: 10.1007/s00228-016-2118-x. Epub 2016 Aug 30.
6
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.
BMC Med Res Methodol. 2016 Feb 19;16:22. doi: 10.1186/s12874-016-0119-1.
7
On the role of marginal confounder prevalence - implications for the high-dimensional propensity score algorithm.
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):1004-7. doi: 10.1002/pds.3773. Epub 2015 Apr 10.

本文引用的文献

1
Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
PLoS Med. 2011 Aug;8(8):e1001075. doi: 10.1371/journal.pmed.1001075. Epub 2011 Aug 16.
2
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.
Am J Epidemiol. 2011 Jun 15;173(12):1404-13. doi: 10.1093/aje/kwr001. Epub 2011 May 20.
3
Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review.
J Am Geriatr Soc. 2010 Sep;58(9):1764-79. doi: 10.1111/j.1532-5415.2010.03025.x.
5
A basic study design for expedited safety signal evaluation based on electronic healthcare data.
Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):858-68. doi: 10.1002/pds.1926.
6
Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.
Circ Cardiovasc Qual Outcomes. 2010 May;3(3):303-8. doi: 10.1161/CIRCOUTCOMES.109.890707. Epub 2010 Mar 30.
7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验